Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center

Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center

Abstract Background We recently upgraded our [18F]fludeoxyglucose (FDG) production capabilities with the goal of futureproofing our FDG clinical supply, expanding the number of batches of FDG we can manufacture each day, and improving patient throughput in our nuclear medicine clinic. In this paper...

Full description

Bibliographic Details
Main Authors: Alexandra R Sowa, Isaac M Jackson, Timothy J Desmond, Jeremiah Alicea, Anthony J Mufarreh, Jonathan M Pham, Jenelle Stauff, Wade P Winton, Maria V Fawaz, Bradford D Henderson, Brian G Hockley, Virginia E Rogers, Robert A Koeppe, Peter J H Scott
Format: Article
Language:English
Published: SpringerOpen 2018-10-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
PET radiochemistry
Cyclotron targetry
Fludeoxyglucose (FDG)
Fluorine-18
Automation
Online Access:http://link.springer.com/article/10.1186/s41181-018-0048-x

Similar Items

Similar Items